Related references
Note: Only part of the references are listed.Elevated Plasma Platelet Activating Factor, Platelet Activating Factor Acetylhydrolase Levels and Risk of Coronary Heart Disease or Blood Stasis Syndrome of Coronary Heart Disease in Chinese: A Case Control Study
Guo-Hua Zheng et al.
INFLAMMATION (2012)
Oxidatively Truncated Phospholipids Are Required Agents of Tumor Necrosis Factor α (TNFα)-induced Apoptosis
Calivarathan Latchoumycandane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
Robert S. Rosenson et al.
JOURNAL OF LIPID RESEARCH (2012)
After Xigris, researchers look to new targets to combat sepsis
Sarah C. P. Williams
NATURE MEDICINE (2012)
Intracellular Erythrocyte Platelet-activating Factor Acetylhydrolase I Inactivates Aspirin in Blood
Gang Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells
Alison A. Gardner et al.
BIOCHEMICAL JOURNAL (2010)
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
Christian C. Yost et al.
BIOCHIMIE (2010)
Chronic Alcohol Exposure Increases Circulating Bioactive Oxidized Phospholipids
Lili Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dual Roles of Endogenous Platelet-Activating Factor Acetylhydrolase in a Murine Model of Necrotizing Enterocolitis
Jing Lu et al.
PEDIATRIC RESEARCH (2010)
Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor
Rui Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
Diana M. Stafforini
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice
Eric Camerer et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Anaphylactic shock depends on endothelial Gq/G11
Hanna Korhonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The emerging roles of PAF acetylhydrolase
Thomas M. McIntyre et al.
JOURNAL OF LIPID RESEARCH (2009)
The Novel Role of Platelet-Activating Factor in Protecting Mice against Lipopolysaccharide-Induced Endotoxic Shock
Young-Il Jeong et al.
PLOS ONE (2009)
Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque
Patrick W. Serruys et al.
CIRCULATION (2008)
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis
Peter Vadas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The lipid whisker model of the structure of oxidized cell membranes
Michael E. Greenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis
Jiawei Chen et al.
JOURNAL OF LIPID RESEARCH (2007)
Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation
Amy N. MacRitchie et al.
FASEB JOURNAL (2007)
A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells -: Cloning and characterization of acetyl-CoA:lyso-PAF acetyltransferase
Hideo Shindou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides
Tamas Kriska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Plasma PAF-acetylhydrolase: An unfulfilled promise?
Sonia-Athina Karabina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases
DM Stafforini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage
GK Marathe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor
QW Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis
RP Choudhury et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2005)
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
S Opal et al.
CRITICAL CARE MEDICINE (2004)
Platelet-activating factor acetylhydrolase: is it good or bad for you?
CH Chen
CURRENT OPINION IN LIPIDOLOGY (2004)
A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow
R Alon et al.
BLOOD (2003)
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription
CH Chen et al.
CIRCULATION (2003)
Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles
GK Marathe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of platelet-activating factor acetylhydrolase II in human skin
M Marques et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
VN Bochkov et al.
NATURE (2002)
Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells
Y Higashimoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Activation of vascular cells by PAF-like lipids in oxidized LDL
GK Marathe et al.
VASCULAR PHARMACOLOGY (2002)
Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells
H Lemjabbar et al.
NATURE MEDICINE (2002)
被撤回的出版物: Lysophosphatidylcholine as a ligand for the immunoregutatory receptor G2A (Retracted article. See vol 307, pg 206, 2005)
JHS Kabarowski et al.
SCIENCE (2001)
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agonists
SS Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hydrolysis of platelet-activating factor by human serum paraoxonase
L Rodrigo et al.
BIOCHEMICAL JOURNAL (2001)
Platelet-activating factor acetylhydrolases in health and disease
LW Tjoelker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Bioactive phospholipid oxidation products
GK Marathe et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Regulation of cell growth by oxidized LDL
GM Chisolm et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model
WR Henderson et al.
JOURNAL OF IMMUNOLOGY (2000)